Thrombolysis restores perfusion in COVID-19 hypoxia

Br J Haematol. 2020 Sep;190(5):e270-e274. doi: 10.1111/bjh.17050. Epub 2020 Aug 17.

Authors

Deepa J Arachchillage^{1

2

3}, Arthur Stacey², Frances Akor⁴, Martin Scotz⁵, Mike Laffan^{1

2}

Affiliations

¹ Department of haematology, Imperial College Healthcare NHS Trust, London, UK.
² Department of Immunology and Inflammation, Imperial College London, London, UK.
³ Department of haematology, Royal Brompton Hospital, London, UK.
⁴ Department of Pharmacology, Imperial College Healthcare NHS Trust, London, UK.
⁵ Department of Intensive Care and Anaesthesia, Imperial College Healthcare NHS Trust, London, UK.

No abstract available

Keywords: bleeding; coronavirus disease 2019; hypoxia; thrombolysis; tissue plasminogen activator.

Publication types

Letter

MeSH terms

Aged
Betacoronavirus / metabolism*
COVID-19
Coronavirus Infections / blood
Coronavirus Infections / complications
Coronavirus Infections / drug therapy*
Female
Humans
Hypoxia / blood
Hypoxia / drug therapy*
Hypoxia / etiology
Male
Middle Aged
Pandemics
Perfusion
Pneumonia, Viral / blood
Pneumonia, Viral / complications
Pneumonia, Viral / drug therapy*
SARS-CoV-2
Thrombolytic Therapy*
Tissue Plasminogen Activator / administration & dosage*

Substances

Tissue Plasminogen Activator